Haloperidol
Product Images NDC 25021-806

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 25021-806). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Hal02 0016 01

Hal02 0016 01
Chemical structure of haloperidol, illustrating its molecular configuration with fluorophenyl, ketone, piperidinyl, hydroxyl, and chlorophenyl groups visible in the diagram.*
FDA Label Image

Hal02 0016 02

Hal02 0016 02
Haloperidol Injection, USP 5 mg per mL single-dose vial label with indication for intramuscular use only. The label shows the product is manufactured by Sagent Pharmaceuticals, Inc., Schaumburg, IL, and is made in Canada. The label includes the NDC 25021-806-01 and features the Sagent logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.